Atherosclerotic disease, evidence-based medicine is rich in evidence

MDT: "Hearts and minds speak together"

Bleeding risk

Cognitive impairment and other effects

Diabetes is one of the high-risk factors for cardiovascular disease, and “sugar and heart are jointly managed”

No increased risk of new onset diabetes

Pay more attention to numbers

Rich evidence: lowering lipids - stabilizing plaque - reducing events

Cardiovascular concepts can be used to influence extracardiac symptoms

Surgeons discount drug treatment

Pay attention to the cerebrovascular group and combine evidence-based medicine

Worry about safety concerns

Surgeons don't pay attention to medication management

Have a basic concept of blood lipid management, and are more recognized for the blood lipid management method of cardiology department

Surgery does not pay attention to drug management

Insufficient evidence-based evidence

Not metabolized by the kidneys

Patients with renal syndrome often have dyslipidemia or coronary heart disease

The patient's basic condition is poor and safety is concerned

Lack of evidence-based evidence and guidance

Patients with atherosclerotic disease have more medical visits

Ruibaian is safe and effective, improving doctors’ diagnosis and treatment level

A relatively basic understanding of plaques

Patients often have multiple medical conditions and are concerned about the safety of biologics and drug-drug interactions.

Ward

outpatient clinic

patient group

Recipe node

strategic activities

Objection handling

Follow up on results